SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > UHN's Shaf Keshavjee is speaking - why aren't we?

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon May 11, 2022 10:20am

52 Views

Post# 34673767

RE:UHN's Shaf Keshavjee is speaking - why aren't we?

Specific to Lung transplants surgeries and the accompanying diagnostic assessments, I think that inquiring investors would like to know more about the monetization plan/strategy, and projections for this highly important pillar of their business.

It's great to have perfected this critical science, but when and how does it create a revenue stream for Spectral? Particularly if it gets adopted stateside (and are there any regulatroy hurdles)?

MM

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec